Peri‐Implant Diseases: Enhanced Antibacterial Photodynamic Therapy
Clinical and Experimental Dental Research · 2025-06 · 11 (3)
DOI: 10.1002/cre2.70146 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Experimental Dental Research, online erschienen am 19.05.2025. Verfasst von Hanna Lähteenmäki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Photochemotherapy, Peri-Implantitis, Anti-Bacterial Agents, Dental Implants. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objectives
The number of dental implants is constantly on the rise, and inflammation of their surrounding tissues is an increasing problem. In this randomized controlled trial, we investigated the effects of antibacterial dual‐light photodynamic therapy (aPDT) in peri‐implant disease in reduction of inflammation in the peri‐implant tissues. Material and Methods Forty patients with newly diagnosed peri‐implant disease were recruited. The diagnoses were established clinically and by radiological bone loss (RBL). Dual‐light aPDT was provided by indocyanine green mouth rinsing and 50:50, 405 nm, and 810 nm light applicator. The treatment group ( n = 20) was randomized to use aPDT treatment at home for 4 weeks. The treatment was carried out once daily for 2 weeks, then twice daily for the next 2 weeks. The control group ( n = 20) continued enhanced self‐care during the study period. Traditional measurement methods around the implant were measured at the beginning, at 2 weeks and at 4 weeks.
Results
During the study period, VPI decreased in both groups. In the treatment group BOP decreased from mean (SD) 4.7 ± 1.3 to 1.8 ± 1.6, p < 0.0001, but no change was observed in the control group (3.5 ± 2.3 to 3.0 ± 2.3, p = 0.39). In the aPDT treatment group aMMP‐8 decreased from mean (SD) 100 ± 41 to 72 ± 38, p = 0.027, but not in the control group (86 ± 54 to 86 ± 60, p = 0.38).
Conclusions
Regularly applied dual‐light aPDT reduces inflammation in the dental implant adjacent tissues. Dual‐light aPDT approach holds promise as an effective home care tool for implant patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Pediatric Heart Surgery and Organ Transplantation, New Children's Hospital, Helsinki University, Helsinki, Finland.
- Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
ORCID-Profile: Ismo T Räisänen
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Lähteenmäki, H., Pätilä, T., Räisänen, I. T., Kalliala, R., & Sorsa, T. (2025). Peri‐Implant Diseases: Enhanced Antibacterial Photodynamic Therapy. Clinical and Experimental Dental Research, 11(3). https://doi.org/10.1002/cre2.70146
Vancouver
Lähteenmäki H, Pätilä T, Räisänen IT, Kalliala R, Sorsa T. Peri‐Implant Diseases: Enhanced Antibacterial Photodynamic Therapy. Clinical and Experimental Dental Research. 2025;11(3). doi:10.1002/cre2.70146
BibTeX
@article{Lhteenmki2025,
author = {Lähteenmäki, Hanna and Pätilä, Tommi and Räisänen, Ismo T and Kalliala, Rauni and Sorsa, Timo},
title = {Peri‐Implant Diseases: Enhanced Antibacterial Photodynamic Therapy},
journal = {Clinical and Experimental Dental Research},
year = {2025},
volume = {11},
number = {3},
doi = {10.1002/cre2.70146}
}
EUVIMED